NewsRx

Search our medical news database

Lung Cancer (Prognostics)

Evaluation of VEGF and MD May Help Predict Lung Cancer Recurrence

Published in Cancer Weekly, October 25th, 1999

It may be possible to predict the recurrence of non-small cell lung cancer in early stages by evaluating the expression of vascular endothelial growth factor and microvessel density in tumors.

Tumor angiogenesis appears to relate to recurrence after an operation as a route for distant metastasis, noted Y. Ohta and colleagues of Japan's Kanazawa University School of Medicine.

Ohta et al. assessed the association of vascular endothelial growth factor (VEGF) expression and intratumoral microvessel density (MD) with recurrence in primary lung cancer ("Tumor Angiogenesis and Recurrence in Stage I Non-Small Cell Lung Cancer," Ann Thorac Surg, September...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook